niaspan
Showing 1 - 9 of 9
Hypercholesterolemia, Hyperlipidemia Trial (Vytorin + Niaspan, Vytorin, Niaspan)
Completed
- Hypercholesterolemia
- Hyperlipidemia
- Vytorin + Niaspan
- +2 more
- (no location specified)
Feb 7, 2022
Peripheral Arterial Disease Trial in Houston (drug, behavioral, procedure)
Completed
- Peripheral Arterial Disease
- Ezetimibe
- +8 more
-
Houston, TexasBaylor College of Medicine
Jan 22, 2020
Dyslipidaemias, Dyslipidemias Trial in United States (GSK256073, Placebo, Niaspan)
Completed
- Dyslipidaemias
- Dyslipidemias
- GSK256073
- +2 more
-
Pembroke Pines, Florida
- +10 more
Nov 19, 2019
Cardiovascular Outcomes Trial in Los Angeles (Niaspan, Placebo)
Completed
- Cardiovascular Outcomes
- Niaspan
- Placebo
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Apr 22, 2019
Dyslipidemia Trial (Niaspan, Comparator: Placebo)
Completed
- Dyslipidemia
- Niaspan
- Comparator: Placebo
- (no location specified)
Oct 9, 2015
Psychosis Trial in Halifax (Niaspan)
Completed
- Psychosis
- Niaspan
-
Halifax, Nova Scotia, CanadaNS Early Psychosis Program
Aug 6, 2015
Healthy Trial in Toronto (Niaspan, TRIA-662)
Completed
- Healthy
- Niaspan
- TRIA-662
-
Toronto, Ontario, CanadaBio Pharma Services Inc. (BPSI)
Aug 21, 2013
Coronary Artery Disease Trial in Los Angeles (Niaspan)
Completed
- Coronary Artery Disease
- Niaspan
-
Los Angeles, CaliforniaCSMC
Sep 13, 2011
Atherosclerosis Trial in Oxford (Niaspan)
Unknown status
- Atherosclerosis
- Niaspan
-
Oxford, United KingdomOxford University
Jan 26, 2007